|
?:abstract
|
-
Objective: COVID 19 is having a devastating effect on mankind\'s life Individuals with COVID-19 will experience high levels of stress, depression, anxiety, and low quality of life The goals the of present study were to investigate the effect of brief crisis intervention package on stress, depression, anxiety, and quality of life in patient with COVID-19 Method: In this randomized controlled clinical trial, 30 patients were randomly selected and divided into control and experimental groups The experimental group was examined in four 60-minute sessions for one month During this period, the control group received only routine treatment and therapy Before and after the intervention, DASS21, the Symptom Checklist (SCL-25), and WHO-QOL were used to measure and record patient mental health and quality of life Finally, data were analyzed using SPSS 24 software Results: The average mental health score was assessed with WHO-QOL, DASS21, and SCL-25 before intervention and was not statistically significant (P = > 0 05), and the mean score of stress, anxiety, depression, WHO-QOL, SCL-25 after intervention was statistically significant (P < 0 001) Therefore, results showed the brief crisis intervention package was effective in improving the quality of life (P < 0 05) and mental illnesses (P < 0 05) in patients with COVID-19 Conclusion: The brief crisis intervention package can reduce the negative effect of patients with COVID-19 Therefore, this intervention can be used as a beneficial treatment to improve mental disorder symptoms and to improve the condition of people who suffer from COVID-19
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}